Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,182 across all filing types
Latest filing 2021-10-14 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
LUPIN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2021 ,inter alia, to consider and approve unaudited financial results for the ....
Regulatory Filings Classification · 95% confidence The document is a notice from Lupin Limited addressed to stock exchanges, informing about a scheduled Board of Directors meeting on October 27, 2021, to consider and take on record unaudited financial results for the quarter and half year ended September 30, 2021. The document is short (798 characters) and serves as an announcement of an upcoming event rather than containing any financial data or results itself. It is not the financial report but a notification about when the report will be considered. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and does not qualify as an Interim/Quarterly Report (IR) or Earnings Release (ER).
2021-10-14 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document text is extremely short (227 characters) and contains only placeholders for omitted pictures with no substantive text content. There is no financial data, no report content, no announcements, no regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement. According to the rules, when a document does not fit any specific category and lacks content, it should be classified as Regulatory Filings (RNS) as a fallback category.
2021-10-11 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015, related to details of share certificates lost and stop transfer requests. It is addressed to the stock exchange and contains details of share certificates and shareholders. The document is short (1388 characters) and serves as a regulatory compliance communication rather than a financial report or announcement of financial results. It does not contain financial data, management discussion, or report content. It is not an announcement of voting results, board changes, or capital changes. It fits best as a Regulatory Filing (RNS) because it is a compliance certificate filing under stock exchange regulations.
2021-10-11 English
Intimation regarding loss of share certificate by the sharehholder.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015. It provides details about the loss of share certificates and a request for stop transfer. The content is a regulatory notification related to share certificate status, not a financial report, earnings release, or management discussion. The document length is short (1370 characters) and it is an official regulatory communication. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-10-11 English
Certificate for the quarter ended at September 30, 2021.
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2021. It is a confirmation certificate from the Registrar and Share Transfer Agent regarding dematerialization of securities and compliance with SEBI regulations. The document is short (3024 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory compliance documents and certifications that do not fit other specific categories.
2021-10-07 English
Lupin Receives Tentative Approval from U.S. FDA for Brexpiprazole Tablets.
Regulatory Filings Classification · 95% confidence The document is a press release announcing Lupin Limited's receipt of tentative U.S. FDA approval for its Abbreviated New Drug Application (ANDA) for Brexpiprazole Tablets. It is a regulatory disclosure pursuant to SEBI Regulation 30, which governs material event disclosures by listed companies. The content is an announcement of a regulatory approval event, not a financial report, earnings release, or management discussion. The document length is 3554 characters, which is relatively short and consistent with a press release or regulatory announcement. There is no financial data, no detailed report, no meeting materials, or voting results. Therefore, the document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and disclosures that do not fit other specific categories.
2021-10-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.